Peptide Diffusion, Protection, and Degradation in Nuclear and Cytoplasmic Compartments before Antigen Presentation by MHC Class I  by Reits, Eric et al.
Immunity, Vol. 18, 97–108, January, 2003, Copyright 2003 by Cell Press
Peptide Diffusion, Protection, and Degradation
in Nuclear and Cytoplasmic Compartments
before Antigen Presentation by MHC Class I
trimmed by cytoplasmic peptidases and again attempt
to associate with MHC class I until they are too small
to be recognized by TAP (Roelse et al., 1994).
Although most players in the process of MHC class I
antigen presentation are known, their kinetic relation-
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ship is unclear. Only a small percentage of peptides1Department of Tumor Biology and Cell Biology
generated will be able to stably bind MHC class I mole-The Netherlands Cancer Institute
cules, and it is unclear why most peptides fail to bindPlesmanlaan 121
MHC class I. A large fraction of peptides may be lost for1066 CX Amsterdam
antigen presentation (Yewdell, 2001; Montoya and Del Val,The Netherlands
1999; Villanueva et al., 1994). Various cytoplasmic pepti-2 Department of Immunohematology
dases may be involved both in generating the correctand Blood Transfusion
epitopes from extended peptides and in full degradationLeiden University Medical Centre
of these peptides. In vitro experiments have revealed2300 RC Leiden
that cytoplasmic peptidases like tripeptidyl peptidase IIThe Netherlands
(TPPII) (Geier et al., 1999), leucine aminopeptidase (LAP)
(Beninga et al., 1998), and thimet oligopeptidase (TOP)
(Mo et al., 1999) are able to degrade peptides with differ-Summary
ent specificities. While TPPII removes N-terminal tripep-
tides stepwise from unblocked oligopeptides, LAP re-Antigenic peptides generated by the proteasome have
moves single hydrophobic amino acids from the Nto survive a peptidase-containing environment for pre-
terminus. The expression of some of these peptidasessentation by MHC class I molecules. We have visual-
is controlled by interferon  (Beninga et al., 1998), sug-ized the fate and dynamics of intracellular peptides in
gesting that they influence the pool of peptides pre-living cells. We show that peptides are distributed over
sented by MHC class I. It is unclear how the heteroge-two different but interconnected compartments, the
neous peptidase pool affects the outcome of MHC classcytoplasm and the nucleus, and diffuse rapidly through
I-restricted antigen presentation. In fact, even for theand between these compartments. Since TAP is ex-
few cytoplasmic peptidases known to date, their relativecluded from the nuclear face of the nuclear envelope,
expression levels and activities have not been defined.nuclear peptides have to leave the nucleus to contact
TAP may compete with cytoplasmic peptidases for pep-TAP. Thereby, these peptides encounter cytosolic
tide substrates, but peptides could also be protectedpeptidases that degrade peptides within seconds un-
against immediate degradation if proteasomes wouldless bound to chromatin. Since peptide degradation
associate directly with TAP or if peptides bind to cyto-is far more efficient than translocation, many peptides
plasmic/nuclear chaperones immediately after produc-will be lost for antigen presentation by MHC class I
tion by the proteasome. The heat shock proteins hsp70molecules.
and hsp90 are thought to protect peptides against pepti-
dase activity by shuttling them through the cytoplasmIntroduction
(Binder et al., 2001). However, there is no direct in vivo
evidence that protection by chaperones occurs duringThe rate and specificity of the various steps in the anti-
peptide transfer from the proteasome to the TAP trans-
gen-processing pathway determine the outcome of a
porter, nor is there any evidence for a direct interaction
MHC class I-restricted response. Many peptides pre-
between the proteasome and TAP. Alternatively, pep-
sented by MHC class I molecules are derived from newly tides may contact TAP by simple diffusion. The effi-
synthesized proteins, but ultimately all intracellular pro- ciency of MHC class I antigen presentation would then
teins will be degraded into peptides and finally into depend on peptide dynamics and intracellular peptidase
amino acids (Schubert et al., 2000; Reits et al., 2000). The activity.
proteasome is the major proteolytic complex involved in Using fluorescent probes, we here describe the fate
the generation of peptides from intracellular proteins of intracellular peptides in living cells. Our data uncovers
(Rock et al., 1994). Proteasomes can generate peptides novel steps in the process of antigen processing and
that are N-terminally extended, and further trimming by presentation. We show that peptides are distributed
aminopeptidases is then required to fit MHC class I over two different but interconnected compartments,
molecules (Mo et al., 1999). Peptides can be trimmed the cytoplasm and the nucleus. Nuclear peptides have
to the correct size for binding to MHC class I molecules to leave the nucleus to contact TAP but then encounter
by ER peptidases (Paz et al., 1999; Serwold et al., 2002), various peptidases like LAP and TPPII which are not
but many peptides will transiently bind to various ER present in the nucleus. Many peptides destined for MHC
chaperones before removal from the ER lumen by the class I loading are targeted by cytosolic peptidases,
Sec61p translocon (Koopmann et al., 2000). After re- as overexpression of the peptidase LAP limits peptide
turning to the cytoplasm, peptides can be further loading of MHC class I molecules. Fluorescent peptides
compete with endogenous peptides in the nuclear com-
partment for binding to chromatin, which decreases the*Correspondence: j.neefjes@nki.nl
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were determined by bleaching a region in the cell and
measuring subsequent recovery of fluorescence in the
same region due to entry of surrounding fluorescent
proteasomes. This technique is called fluorescence re-
covery after photobleaching (FRAP) (reviewed by Meyvis
et al., 1999; Lippincott-Schwartz et al., 2001; Reits and
Neefjes, 2001). FRAP showed that proteasomes freely
diffuse within the nuclear and cytoplasmic compart-
ment, and were only very slowly transported into the
nucleus in a unidirectional manner (Reits et al., 1997).
TAP1-GFP was localized to the ER network and the
nuclear envelope (Figure 1A).
Previous studies showed that cytosolic peptides can-
not be detected unless bound to MHC class I molecules
(Falk et al., 1991) or small molecular weight proteins
(Paz et al., 1999). This suggests that free peptides are
unstable. To visualize peptide distribution in vivo, we
generated a fluorescein-labeled peptide composed of
D amino acids (TAE[K-fluorescein]TEKAY), which is
protected from degradation by peptidases (data not
shown). When microinjected in living cells, peptides dis-
tributed throughout the cytoplasm and the nucleus (Fig-
ure 1A). Since TAP does not recognize D peptides
(Gromme et al., 1997), the ER lumen was excluded. The
peptide distribution resembled the distribution of pro-
teasomes, but peptides were also present in nucleoli.
A fraction of the peptides concentrated in the nucleus,
suggesting interactions with nuclear factors. In order to
determine the diffusion rate of peptides in vivo, a line-
scan FRAP protocol was applied (described in the Ex-
perimental Procedures). These experiments showedFigure 1. Distribution and Mobility of Proteasomes, TAP, and Pep-
that peptides diffuse rapidly within the nuclear and cyto-tides in Living Cells
plasmic compartments. The mean mobility of free pep-(A) The distribution of GFP-tagged proteasomes, GFP-tagged TAP,
tides was much faster than that of proteasomes (750and fluorescein-labeled D peptides in living Mel JuSo cells at 37C.
Scalebar, 3 m. kDa for the 20S core) or free GFP (27 kDa) (Figure 1B).
(B) Mobility of fluorescein-labeled D peptides, free GFP, and GFP- The mobility of peptides, GFP, and proteasomes was
tagged proteasomes within the cytoplasm and the nucleus as deter- not affected by ATP depletion, implying that they move
mined by FRAP analysis measured in living Mel JuSo cells at 37C. by diffusion (data not shown). A difference in diffusion
of soluble proteins is mostly due to a difference in size,
as reflected by the Stokes-Einstein formula that corre-
rate of degradation. This could be important during mito- lates the hydrodynamic behavior of a sphere mainly to
sis as peptides generated from proteins expressed dur- its radius (Arrio-Dupont et al., 1997). Since fluorescent
ing the cell cycle would be preserved for antigen presen- peptides moved faster than GFP, the majority of the
tation by binding to chromatin. Although peptides move introduced peptide molecules should be free rather than
fast, the rate of degradation allows them to move only associated to larger diffusing proteins.
once through a cell before being degraded. Since pep-
tides only have a limited time to find TAP, most peptides Dynamics of Peptides in and between the Nucleus
will be lost for antigen presentation by MHC class I and the Cytoplasm
molecules. The high mobility of intracellular fluorescent peptides
did not exclude that a fraction of these peptides was
Results transiently associated to other structures. When these
structures have a low mobility and a defined localization,
Distribution and Dynamics of Peptides in the MHC associated peptides would behave accordingly. To visu-
Class I Processing Pathway alize the dynamics of the different peptide fractions, a
To visualize different components of the MHC class region in the cytoplasm or in the nucleus was bleached,
I-processing pathway in vivo, the human melanoma cell and fluorescence was determined before and after
line Mel JuSo was stably transfected with the proteaso- bleaching for both compartments. When a cytoplasmic
mal subunit LMP2 or the TAP subunit TAP1, both tagged region was bleached, fluorescence recovered to levels
with the green fluorescent protein (GFP) and analyzed comparable to other cytoplasmic regions within the
by confocal microscopy (Reits et al., 1997, 2000). Pro- same cell (Figure 2A, cytoplasm region 1 was bleached).
teasomes were distributed over two compartments, the Nuclear fluorescence also decreased but remained
nucleus and the cytoplasm, and excluded from what higher compared to the cytoplasm. Apparently, peptides
is probably the ER, the nuclear envelope, and nucleoli can freely diffuse through the cytoplasm and between
the cytoplasmic and the nuclear compartment.(Figure 1A). The dynamics of GFP-tagged proteasomes
Intracellular Peptides In Vivo
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Figure 2. Dynamics of Peptides in and be-
tween Nucleus and Cytoplasm
(A) Dynamics of cytoplasmic fluorescent D
peptides in living Mel JuSo cells at 37C. After
introduction of peptides by microinjection,
fluorescence in cytoplasmic region 1 was
bleached, and fluorescence was monitored
in the indicated cytoplasmic and nuclear re-
gions. The graph quantifies levels of fluores-
cence within the indicated regions before and
after bleaching. The gray bar indicates the
bleaching.
(B) Dynamics of nuclear fluorescent D pep-
tides. After introduction of the peptide by mi-
croinjection, region 1 in the nucleus was
bleached, and fluorescence was monitored
in the indicated nuclear and cytoplasmic re-
gions. The graph quantifies levels of fluores-
cence within the indicated regions before and
after bleaching. The gray bar indicates the
bleaching.
To measure the mobility of the nuclear peptide frac- lated on condensed chromatin (Figure 3A, top two pan-
els). To exclude that binding is fluorescein-mediated,tion, a region in the nucleus was bleached. A decrease
in both cytoplasmic and nuclear fluorescence was ob- fluorescein-labeled dextran was incubated with chro-
matin. A negative image was observed, indicating thatserved due to rapid diffusion rate of the mobile pool of
peptides (Figure 2B, nucleus region 1 was bleached). dextran-fluorescein was excluded from chromatin (Fig-
ure 3A, bottom panel). To further exclude an effect ofWhen compared to the cytoplasm, fluorescent recovery
within the bleached area of the nucleus was slower, the packing of condensed chromatin, decondensed frog
chromatin was generated in vitro, which formed an artifi-suggesting that a fraction of the microinjected peptide
pool is interacting with nuclear molecules. Apparently cial nucleus. Similar to condensed chromatin, fluores-
cent L peptides accumulated on decondensed chroma-nuclear peptides are present in two pools, a mobile
fraction in rapid equilibrium with the cytoplasm, and a tin (Figure 3B). FRAP experiments on both forms of
chromatin incubated with fluorescent peptides showedrelatively slower pool bound to nuclear proteins. ATP
depletion did not affect the rate of peptide mobility or recovery of fluorescence in the bleached area (data not
shown), suggesting dynamic chromatin association.the accumulation in the nucleus (data not shown), sug-
gesting that peptides move by diffusion and that nuclear One exception to the cytoplasm/nucleus two-com-
partment peptide model is mitosis when the nuclearaccumulation is not the result of an active (ATP-depen-
dent) process. envelope is dissolved, and cytoplasmic peptidases and
peptide binding chromatin are not physically separated.
To test whether fluorescent peptides still associate toPeptides Bind to Chromatin-Associated Proteins
chromatin during mitosis, the N-terminally protected flu-The immobile nuclear peptide pool appeared to be
orescent L peptide was coinjected with ethidium bro-equally distributed throughout the nucleus and was not
mide (to stain DNA) into mitotic Mel JuSo cells. Fluores-enriched in areas like nuclear speckles. Possible peptide
cent peptides associated very efficiently with the alignedbinding proteins within the nucleus are chromatin-asso-
condensed chromosomes during mitosis (Figure 3C).ciated proteins, as the chromatin network is widely dis-
This may provide protection against cytosolic pepti-tributed and relative immobile (Phair and Misteli, 2000).
dases which are no longer separated from chromo-To examine whether chromatin has a peptide binding
somes by the nuclear envelope.capacity, isolated condensed frog sperm chromatin was
To determine which nuclear proteins were able toincubated with the fluorescein-labeled L and D amino
acid peptides in vitro. Fluorescent peptides accumu- bind peptides, a photoaffinity-labeling experiment was
Immunity
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Figure 3. Binding of Peptides to Chromatin-
Associated Molecules
(A) Binding of peptides to chromatin in vitro.
Fluorescein-labeled D peptide (top panel), L
peptide (middle panel), or dextran (bottom
panel) was added to purified frog sperm chro-
matin, and distribution was visualized by con-
focal imaging.
(B) Binding of peptides to decondensed chro-
matin in vitro. Fluorescent L peptides were
added to purified frog sperm chromatin de-
condensed in vitro, and distribution was visu-
alized by confocal imaging.
(C) Peptide distribution during mitosis. N-ter-
minally protected fluorescent L peptide Fmoc-
T[C-fluorescein]NKTERKY was coinjected
with ethidium bromide (EtBr, to stain DNA)
into mitotic Mel JuSo cells and analyzed by
CLSM. The transmission image shows aligned
and condensed chromosomes that stain for
the fluorescent peptides and EtBr, as indi-
cated.
(D) Identification of peptide binding nuclear
proteins. Purified human chromatin was incu-
bated with radio-iodinated peptide 5PS1 in
the presence or absence of ATP or competing
peptide p417. After UV exposure, chromatin
was analyzed by 15% SDS-PAGE. A limited
set of radiolabeled proteins was visualized.
Arrows indicate the two proteins identified.
The last lane represents the iodinated peptide
5PS1.
(E) Peptide binding chromatin-associated
proteins. Human chromatin-associated pro-
teins were separated by 2D IEF/SDS-PAGE,
and spots corresponding to photoaffinity-
labeled proteins were excised. Peptide frag-
ments were analyzed by mass spectrometry.
The peptide sequence and corresponding
proteins are indicated.
performed with the radio-iodinated peptide 5PS1 (Spee absence or presence of ATP and competing nonradioac-
tive peptides, and subsequently exposed to UV light. Aet al., 1999). This peptide contained a photoreactive
group that allowed covalent photoaffinity labeling upon number of proteins were visualized in the absence or
presence of ATP (Figure 3D). Incubation with increasingUV exposure. Isolated condensed human sperm chro-
matin was briefly incubated with peptide 5PS1 in the amounts of competing, cold peptides resulted in a con-
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Figure 4. TAP in the Nuclear Envelope
(A) Living Mel JuSo cells expressing TAP-GFP
were analyzed at 37C. Different regions in
the ER network (indicated by ER1-3) were
bleached, and loss in fluorescence was mea-
sured as a function of time in the bleached
ER regions and in two indicated regions in
the nuclear envelope (nucl 1 and 2) of the
same cell. The quantitation shows similar loss
in fluorescence of the nuclear envelope and
the ER network. The slight delay in the second
nuclear region is probably due to its distance
from the bleached ER regions.
(B) Mel JuSo cells were fixed, and cryosec-
tions were labeled with an antibody against
the nucleotide binding domain of TAP1 fol-
lowed by immunogold (10 nm) labeling.
Arrows show the location of gold particles
close to the nuclear envelope. The inset
shows a higher magnification of the double
membrane of the nuclear envelope. The cyto-
plasm (C) and nucleus (N) are indicated. Mag-
nification, 11,500 (inset 46,000).
centration-dependent decrease of photoaffinity-labeled fluorescent pool of TAP molecules within the ER region.
Repeated bleaching of a membrane region will ulti-proteins. To identify the peptide binding proteins, these
proteins were separated by 2D IEF/SDS-PAGE. In a par- mately lead to loss of fluorescence of molecules diffus-
ing within connected membranes (Poo and Cone, 1974),allel experiment nonlabeled proteins were separated
and stained by Coomassie, and spots corresponding a variation of FRAP called FLIP (fluorescence loss in
photobleaching) (Cole et al., 1996). Since the nuclearto the photoaffinity-labeled proteins were analyzed by
mass spectrometry after trypsin digestion. Peptides pore restricts diffusion, only TAP present in the outer
nuclear membrane can rapidly be exchanged with TAPwere sequenced (Figure 3E) and identified as histone
H2B and H4. present in the ER network. Three regions in the ER net-
work were bleached, each for a period of 10 s, resulting
in an almost complete loss of fluorescence of the ERPeptides and TAP Location
network. When measuring fluorescence of the nuclearThe TAP transporter is present in the ER membrane and
envelope, fluorescence dropped to the same level withthe connected nuclear envelope (Figure 4A). The outer
almost identical dynamics (Figure 4A). If TAP had beennuclear membrane is directly connected to the ER mem-
equally distributed over the inner and outer membranesbrane, while the inner membrane facing the nucleoplasm
of the nuclear envelope, a reduction in fluorescence ofis connected with the outer membrane via the pore
about 50% would have been observed. However, a lossmembrane domain, which restricts diffusion of large
of around 93  3% (mean  SEM, n  6) of fluorescenttransmembrane molecules (Soullam and Worman, 1995;
TAP-GFP in the nuclear envelope was observed. Appar-Ellenberg et al., 1997). Nuclear peptides could either
ently, the nuclear envelope was able to exchange virtu-enter the cytoplasm to reach TAP present in the ER
ally all TAP transporters with the pool of TAP transport-membrane or directly access TAP from the nuclear side
ers bleached in the ER network.of the nuclear envelope. If so, peptides would be enter-
To confirm that TAP is distributed only on the cyto-ing the ER lumen from two different compartments: the
plasmic face of the nuclear envelope, untransfected Melcytoplasm, containing peptidases like TPPII and LAP
JuSo cells were fixed and cryosections were stained(Figure 5B), and the nucleus. To determine whether TAP
with antibodies against the cytoplasmic nucleotidewas present in the inner nuclear membrane, we repeat-
edly bleached TAP-GFP-expressing cells to deplete the binding domain of TAP1. Electron microscopy showed
Immunity
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Figure 5. Endogenous Peptides in Living Cells
(A) Fluorescent peptides compete with endogenous peptides for binding to nuclear proteins. The ratio of nuclear versus cytoplasmic fluores-
cence was determined. Cells were injected with an N-terminally protected fluorescent L peptide, either alone or with competing (nonfluorescent)
peptides. Competition with endogenous peptides for nuclear binding was tested by infecting cells with influenza virus (increasing the endoge-
nous peptide pool) or treatment with lactacystin (blocking the proteasome) (mean  SEM, n  9).
(B) The intracellular distribution of two peptidases. Tagged bovine leucine aminopeptidase (LAP) was transiently expressed in Cos7 cells.
Endogenous tripeptidyl peptidase II (TPPII) was examined in Mel JuSo cells. Cells were fixed, stained with antibodies, and analyzed by CLSM.
(C) Overexpressing bLAP reduces the peptide pool for MHC class I loading. Western blot analysis of lysates generated from Cos7 cells after
transfection with VSV-bLAP (left panel). The same Cos7 cells were biosynthetically labeled with 35S-Met/Cys for 1 hr. Lysates were incubated
at either 4C or 37C for 30 min before isolation of MHC class I complexes and separated by 10% SDS-PAGE.
gold particle staining exclusively on the cytoplasmic peptides have to enter the cytoplasm for TAP transloca-
tion into the ER lumen.side of the nuclear envelope (Figure 4B, 150 gold parti-
cles on the cytoplasmic side, none on the nuclear side).
TAP is apparently excluded from the nuclear face of the Endogenous Peptides in Living Cells
In our study, fluorescent peptides were introduced innuclear envelope in agreement with the data obtained
from FLIP analysis. These findings imply that nuclear cells to describe the dynamics of peptides in vivo. To
Intracellular Peptides In Vivo
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test whether the fluorescent peptides do behave like Peptide Degradation in Living Cells
To detect peptidase activity in vivo, we designed a 9-merendogenous peptides, we examined competition of fluo-
L amino acid peptide that would become fluorescentrescent peptides with endogenous peptides for nuclear
only after degradation by peptidases. The quenchedaccumulation. Therefore an N-terminally modified fluo-
peptide (T[C-fluorescein]NKTER[K-Dabcyl]Y) contains arescent L peptide (Fmoc-T[C-fluorescein]NKTERKY) was
fluorescein group and a Dabcyl quencher group coupledused that was protected against aminopeptidases
to amino acids 2 and 8, respectively. The Dabcyl group(shown later). These peptides showed an intracellular
efficiently quenches emission of the nearby fluoresceindistribution similar to that of D peptides (Figure 5A).
group, and fluorescence will only be detected whenFirst, fluorescent peptides were microinjected in the
amino acids 2 and 8 are separated as the result of pepti-presence of a 10-fold molar excess of its nonfluorescent
dase activity (Figure 6A). When added to PBS in vitro,counterpart (Figure 5A). Accumulation of fluorescence
fluorescence remained very low (Figure 6B, t 0). How-decreased in the nucleus (a fluorescence nucleus/cyto-
ever, when a cytosolic extract containing peptidasesplasm ratio of 1.16 instead of 1.27 when injected with
was added (arrow), fluorescence rapidly increased duefluorescent peptides only), implying that peptides com-
to separation of the quencher and the fluorescein moi-peted for nuclear binding. To increase the pool of endog-
ety. Since binding to chromatin may temporarily protectenous peptides, cells were infected with influenza virus
peptides against degradation, we did the same experi-(Reits et al., 2000). Again, fluorescent peptide accumula-
ment in the presence of purified chromatin. Upon addi-tion within the nucleus dropped (to a ratio of 1.14), im-
tion of cytosol, a reduced rate of peptide degradationplying that microinjected peptides competed with en-
was observed (Figure 6B) due to the dynamic interactiondogenous peptides for nuclear binding. To decrease
between peptides and chromatin.competition for nuclear binding, cells were incubated
The peptide degradation experiment was repeated inwith the proteasome inhibitor lactacystein for 1 hr to
vivo by microinjecting the quenched peptide into Meldeplete the endogenous peptide pool. Nuclear accumu-
JuSo cells. Fluorescence appeared almost immediatelylation of introduced fluorescent peptides increased (ra-
after microinjection (Figure 6C, indicated by arrow). Deg-tio of 1.48), suggesting that more peptide binding sites
radation went to completion with a half-life of 7 s (t1/2 were available. Apparently endogenous peptides be-
7.0  1.1 s, mean  SD). Prolonged measurement ofhaved similarly to fluorescent peptides and actually
microinjected cells (up to 5–10 min) did not show anycompeted with each other for nuclear binding. The
further increase in fluorescence. The process of degra-amount of introduced fluorescent peptides (approxi-
dation was not saturated because microinjection of amately 2  105 peptides) should be comparable to the
10-fold higher amount of this peptide yielded identicalendogenous pool since nuclear binding of fluorescent
degradation rates (data not shown). To exclude any ef-peptides can be reduced by increasing and improved
fect on the quencher molecule, resulting in increasedby eliminating the endogenous peptide pool.
fluorescence without degradation of the peptide, theStill, the pool of peptides presented by MHC class I
same experiments were repeated with a 9-mer peptidemay not be diffusing freely through the cell but may
containing a fluorescein and a tetramethylrhodamineinstead be protected against degradation by binding to
(TMR) FRET pair (T[C-TMR]NRTER[C-fluorescein]Y). Mi-and transfer by chaperones, or directly delivered to TAP
croinjection of this peptide resulted in decreased redby proteasomes. To test this, VSV-tagged bovine leucine
and increased green fluorescence when the fluoresceinamino peptidase (bLAP) was overexpressed in Cos7
was excited (at 475 nm), indicating separation of thecells. VSV-tagged bLAP was present in the cytoplasm
two fluorophores. No change in red (TMR) fluorescencebut excluded from the nucleus (Figure 5B). This was
was measured when the TMR was excited directly (atidentical to the distribution of the peptidase TPPII in Mel
545 nm) (data not shown). Apparently, the acceptorJuSo cells, which was also excluded from the nucleus
group was not quenched after microinjection in living(Figure 5B). Western blotting of VSV-bLAP transfected
cells.Cos7 cells revealed bLAP in transfected cells (Figure
It is unclear whether small peptides are targeted ex-5C, left panel). Forty-eight hours after transfection, VSV-
clusively by aminopeptidases or also by carboxy and
bLAP and mock-transfected cells were biosynthetically
endopeptidases (including the proteasome) in vivo.
labeled for 1 hr. NP40 lysates were split in halves and Aminopeptidase activity can be inhibited by modifying
either maintained at 4C (to stabilize both peptide- the free N terminus of the peptide (Mo et al., 1999).
loaded and free MHC class I molecules) or 37C (to We repeated the experiment as described above and
dissociate the peptide-free MHC class I molecules) for microinjected the same quenched-fluorescent peptide
30 min before isolation of stable MHC class I complexes coupled to an N-terminal Fmoc group (Fmoc-T[C-fluo-
with the mAb W6/32 (Schumacher et al., 1990). Whereas rescein]NKTER[K-Dabcyl]Y). No increase in fluores-
MHC class I molecules were temperature stable (i.e., cence was observed, implying that this peptide was not
peptide-loaded) in mock-transfected cells, about half degraded (Figure 6C) and that the quencher was not
of the MHC class I molecules dissociated under these inactivated. This suggests that in vivo aminopeptidases
conditions in cells overexpressing bLAP (Figure 5C). are responsible for the degradation of these peptides,
Apparently, an increase in peptidase activity reduces instead of carboxy and endopeptidases (like the pro-
the available peptide pool for MHC class I molecules. teasome).
These peptides should be free to access the active cen- Since introduced peptides have to compete with en-
ter of peptidases like bLAP (Burley et al., 1992) which dogenous peptides for degradation or potential binding
suggests that a large pool of peptides destined for MHC to chaperones, we treated cells with lactacystin to block
class I loading can also be substrate for cytosolic pepti- peptide generation by the proteasome resulting in a
small increase in the half-life (t1/2  9.7  1.3 s, mean dases.
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Figure 6. Peptide Degradation in Living Cells
(A) Detecting peptidase activity. The quenched-
fluorescent peptide T[C-fluorescein]NKTER-
[K-Dabcyl]Y contains a fluorescein group (F)
and a Dabcyl quencher group (Q). The quencher
Q efficiently absorbs emission of the nearby
fluorescein group F, and fluorescence will
only be detected when these amino acids are
separated following peptidase activity.
(B) Degradation of peptides in vitro. Quenched-
fluorescent peptides were incubated in PBS
in the absence or presence of purified frog
sperm chromatin. Only when cytosol was
added (arrow), degradation of peptides was
observed by an increase in fluorescence. The
presence of chromatin reduced the rate of
degradation.
(C) Degradation of quenched fluorescent
peptide and its N-terminally protected form
in living Mel JuSo cells at 37C. At the time
point indicated (arrow), equal amounts of ei-
ther unprotected or N-terminally protected
quenched-fluorescent peptides were mi-
croinjected.
SD). Cells were also treated with cycloheximide to inhibit (Neefjes et al., 1993). To examine the relative efficiencies
of peptide degradation versus translocation into the ERprotein synthesis. This resulted in less endogenous pep-
tides generated from newly synthesized proteins (Reits (mimicking the in vivo situation), we introduced a fluores-
cein-labeled peptide (T[C-fluorescein]NKTERKY). Thiset al., 2000) and should enhance the pool of peptide-
receptive chaperones normally involved in protein fold- unprotected fluorescent peptide contained an N-linked
glycosylation site that would be glycosylated and re-ing. Again, only a small increase in the half-life of mi-
croinjected peptides was observed (t1/2  8.7  1.4 s). tained in the ER when translocated by TAP (Neefjes et
al., 1993). To show translocation of this peptide into theATP depletion did not affect the half-life. Together these
data suggest that most introduced peptides are not pro- ER, the peptide was iodinated and incubated for various
times with human microsomes in the absence or pres-tected but rapidly degraded by cytosolic peptidases.
ence of ATP. Glycosylated peptides were recovered by
Con A-Sepharose and quantified (Figure 7A). The iodin-Peptide Degradation versus TAP Translocation
Fluorescent N-protected L peptides rapidly moved in ated fluorescent peptide was translocated by TAP in a
time- and ATP-dependent fashion.the cytoplasm (faster than a 27 kDa protein GFP, Figure
1B) and were not excluded by the nuclear pore, indicat- If a substantial fraction of introduced peptides would
be translocated by TAP, the ER lumen would accumulateing that they were not associated with proteins larger
than 50–60 kDa (Mattaj and Englmeier, 1998), including fluorescence. To compare the rate of peptidase activity
versus peptide translocation by TAP in vivo, the fluores-most heat shock proteins. Although they can associate
to HSPs in vitro (Takeda and McKay, 1996), these pep- cent peptide was microinjected into Mel JuSo cells and
cultured for 30 min. Confocal analysis showed a randomtides were not translocated into the ER because pep-
tides require a free N terminus for recognition by TAP distribution in the nuclear and cytoplasmic compart-
Intracellular Peptides In Vivo
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Figure 7. Peptide Degradation and TAP
Translocation in Living Cells
(A) Fluorescent peptides are translocated by
TAP. Iodinated peptide T[C-fluorescein]
NKTERKY was incubated with microsomes
at 37C in the presence or absence of ATP for
the times indicated. Translocated peptides
were isolated and quantified.
(B) Distribution of free and N-terminal pro-
tected fluorescent peptides (T-C[fluorescein]-
NKTERKY) upon microinjection in living Mel
JuSo cells.
(C) Peptide degradation versus TAP-translo-
cation in vivo. The fluorescent peptide T[C-
fluorescein]NKTERKY was microinjected in
Mel JuSo cells and analyzed after 30 min. The
peptide contains a glycosylation site re-
taining it in the ER after translocation by TAP.
Using a fluorescence loss in photobleaching
protocol, fluorescent nuclear and cytosolic
peptides were depleted by repeatedly bleach-
ing a nuclear region within one cell for 2 s with
intervals allowing redistribution of diffusing
peptides (bleaches indicated by the dashed
lines). Fluorescence in the nucleus, cyto-
plasm, ER, and a control cell are quantified.
ment, and some exclusion from the ER region (Figure cence were quantified. Repeated bleach pulses quan-
titatively reduced both nuclear and cytosolic fluorescence7B). This represented the distribution of a peptide degra-
dation product that differed from the distribution of an close to background levels (Figure 7C). Apparently, no
substantial pool of (glycosylated) fluorescent peptidesN-terminally protected peptide that was not degraded.
If translocation by TAP would be as efficient as peptide was retained in the ER lumen, suggesting that peptide
degradation was far more efficient than peptide translo-degradation in vivo, a substantial fraction of the fluores-
cent peptide pool would accumulate in the ER despite cation into the ER by TAP.
the short half-life of similar 9-mer peptides. Once trans-
located into the ER by TAP, the fluorescent peptide is Discussion
glycosylated and can be distinguished from cytosolic
peptides and peptide degradation products by bleach- The MHC class I antigen presentation pathway is a dy-
namic process involving protein degradation and pre-ing the nuclear peptide pool. Since peptides diffused
freely between the nucleus and cytoplasm, the cytosolic sentation of the resulting peptides. Various dedicated
proteins are involved in this pathway, including the pep-pool of free fluorescent peptides would decrease as well
(see also Figure 2B). To deplete the cell of cytosolic tide transporter TAP, a specialized chaperone tapasin
and immuno-proteosomal subunits. Still, both theoreti-fluorescence without affecting translocated peptides
within the ER lumen, the nucleus was bleached multiple cal calculations and experimental data suggest that anti-
gen processing is very inefficient. It has been estimatedtimes and the effects on cytoplasmic and ER fluores-
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that on average 102 (Villanueva et al., 1994) to 104 (Yew- While most peptides simply diffuse from proteasomes
dell, 2001; Montoya and Del Val, 1999) proteins need to to TAP, it cannot be excluded that some proteasomes
be degraded for every single peptide in a MHC class I directly deliver their peptides to TAP. However, a direct
complex. Since the processes of peptide transport by association between proteasomes and TAP has never
TAP (Reits et al., 2000) and peptide binding by MHC been found. Moreover, since TAP is absent in the nu-
class I molecules (Benham and Neefjes, 1997) are not cleus, direct delivery of peptides derived from nuclear
occurring at saturated levels, many peptides are possi- proteins would be impossible. By overexpressing the
bly lost between generation by the proteasome and as- peptidase LAP, a clear reduction in peptide loading of
sociation with TAP. Only little is known about the fate of MHC class I molecules is observed. Not all peptides for
these peptides, which is surprising as it is an important MHC class I molecules were destroyed which could be
phase in the sequence of events resulting in antigen due to LAP specificity or simply because some peptides
presentation. contact TAP before peptidases. Still, these data indicate
Here we have studied the fate of peptides in living that a large fraction of peptides destined for MHC class
cells. Like proteasomes, peptides are located in both I loading are targeted by cytosolic peptidases. This pep-
the cytoplasmic and nuclear compartments, but unlike tide pool must be free to access peptidases and are
proteasomes (Reits et al., 1997) peptides rapidly diffuse not protected by chaperones or directly delivered by
into and out of the nucleus. The nuclear pore connecting proteasomes to TAP. We cannot, however, exclude that
these two compartments does not form a diffusion bar- a fraction of peptides is not freely diffusing and is not
rier for small particles like peptides. Still, these compart- handled differently. Still, the majority of peptides is free
ments are different from the peptide’s point of view. rather than associated to cytosolic chaperones. This is
First, certain peptidases like TPPII and LAP are excluded evident from various observations including FRAP data
from the nuclear compartment. Such large peptidase showing free mobility of peptides in the cytoplasm and
complexes would require a nuclear localization signal unhindered transfer through the nuclear pore. Further-
to enter the nucleus. It is unknown whether the nucleus more, all introduced peptides are rapidly degraded even
contains peptidases at all, as chromatin lacks such ac- when the available chaperone pool is increased. This
tivities. There is, however, no explicit need for nuclear suggests that in vivo peptide-chaperone interactions
peptidases since peptides generated in the nucleus can are at best very transient if occurring at all. Still, highly
rapidly enter the cytoplasm. Second, the dynamic inter- efficient delivery of gp96 or other ER chaperone-associ-
action of peptides with chromatin reduces their availabil- ated peptides into the MHC class I pathway has been
ity as substrates for peptidases. Interacting proteins reported (Basu et al., 2001; Binder et al., 2001). This can
include histone H2B and histone H4. It is unclear why be envisioned when such a protein-peptide complex is
these histones have some affinity for peptides. Since relatively stable and able to deliver peptides efficiently
histones are expressed at high levels, accumulation of to the MHC class I-loading complex. This may also be
peptides in the nucleus may be the result. Shastri and the case for chromatin-bound peptides during uptake
coworkers identified a peptide pool associated to small of apoptotic bodies.
molecular weight proteins (around 20 kDa) (Paz et al., We have shown by confocal imaging and electron
1999) that could represent histones (14 kDa). It remains microscopy that TAP is excluded from the nuclear side
to be examined whether chromatin influences delivery of of the nuclear envelope. This implies that nuclear pep-
a specific peptide pool to the MHC class I presentation tides have to leave the nucleus through the nuclear pore
pathway and whether peptides bind with different affini- and enter the cytoplasmic compartment before they can
ties. The binding of peptides to chromosomes may tem- encounter TAP. Given their rate of diffusion (around 3
porarily protect peptides derived from short-lived pro- m2s1), a peptide will move about 2.45 m per s (calcu-
teins specifically expressed during mitosis, until the ER lated with Einstein’s formula x2  2 Dt, with x2, average
has been reassembled after cell division and production value for the square of the distance; D, diffusion coeffi-
of MHC class I molecules is restored. The observation cient; and t, time). A peptide will thus diffuse through
that peptides bind to chromatin could be relevant for the entire cell in 6 s and has to find TAP within this short
vaccination and crosspriming with apoptotic bodies. By period for translocation into the ER lumen. Nine-mer
preventing accessibility to peptidases, chromatin could
peptides have a very short half-life in vivo (around 7 s),
stabilize peptides during apoptosis or necrosis and
and given the number of TAP molecules expressed in
would thereby improve successful peptide delivery to
a cell (and the time required for translocation), theantigen-presenting cells (APCs) in a similar way as sug-
chance of making the correct interaction is very small.gested for gp96 and other chaperones.
This is further illustrated by the observation that intro-We showed that peptides are degraded in vivo by
duction of a fluorescent peptide with a glycosylationaminopeptidases. No carboxypeptidase activity was de-
site in living cells showed no accumulation in the ERtected. Proteasomes have been reported to generate
where the translocated peptide would have been re-the correct C terminus of presented peptides but not
tained. Apparently, cytoplasmic peptide degradation isnecessarily the correct N terminus (Cascio et al., 2001).
far more efficient than peptide translocation into the ERAminopeptidases can further trim the peptide to the
lumen.correct size for MHC class I binding and beyond. Correct
generation of the peptide C terminus is essential when
Experimental Procedurescarboxypeptidase activity is absent, underlining the
need for correct C-terminal cleavage by the proteasome, Cell Lines, DNA Constructs, and Immunostaining
especially when ER peptidases lack carboxypeptidase The human melanoma cell line Mel JuSo stably transfected with
activity for such trimming (Fruci et al., 2001; Paz et al., TAP1-GFP has been described before (Reits et al., 2000). LMP2-
GFP expressing Mel JuSo cells were generated as described (Reits1999; Serwold et al., 2002).
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et al., 1997). Mel JuSo cells were used for microinjection of peptides. 1.3 m (full width, half maximum) were bleached (95%) using a
single 30 ms pulse from the ArKr laser during data collection in line-The cDNA for bovine leucine aminopeptidase was provided by Dr.
A. Taylor (Wallner et al., 1993). The stopcodon was replaced by a scan mode at 1000 Hz. The half-time for recovery was calculated
from each recovery curve after correction for loss of fluorescenceVSV tag, and the construct was cloned into pMT2. Isolated bLAP
by anti-VSV antibodies was fully functional in vitro. Cos7 cells were due to imaging (usually less than 4%). The diffusion coefficient D was
determined as described (Reits et al., 2000). For peptide competitiontransiently transfected with VSV-tagged LAP, fixed with methanol,
and stained with anti-VSV antibodies and processed for confocal experiments in vivo, cells were incubated at 37C in the presence
of 10 M lactacystin for 60 min to inhibit proteasomes, coinjectedanalysis 2 days after transfection. Endogenous TPPII was visualized
by staining fixed Mel JuSo cells with the anti-TPPII antibody WL- with a 10-fold molar excess of nonfluorescent peptides, or incubated
for 2 hr with influenza A virus strain A/NT/60/68 (Reits et al., 2000)26 (kindly provided by Martha Imreh, Karolinska Institute) before
analysis by CLSM. For EM analysis, Mel JuSo cells were fixed in before peptide injection. Mitotic cells were selected by their
rounded-up appearance and aligned chromosomes, and analyzed0.5% glutaraldehyde and 4% paraformaldehyde in 0.1 M phosphate
buffer (pH 7.2) and processed for ultrathin cryosectioning. Sections by CLSM after microinjection of a mixture of N-terminally protected
fluorescent peptides (ex/em: 488/520 nm) and EtBr (488/625 nm).were incubated with purified mAb anti-human TAP1 198.3 (provided
by R. Tampe´, Germany) and analyzed by a Philips CM10 electron
microscope (Eindhoven, The Netherlands). Chromatin Preparation, Peptide Crosslinking,
and Mass Spectrometry
Synthetic Peptides Chromatin was isolated using a modified protocol (Gurdon, 1976).
List of peptides used: fluorescent peptide, T[C-fluorescein] Human sperm was washed twice with PBS at 4C, followed by a
NKTERKY; quenched peptide, T[C-fluorescein]NKTER[K-Dabcyl]Y; single wash with HSP buffer (250 mM sucrose, 15 mM Tris-HCl
FRET peptide, T[C-TetraMethylRhodamine]NRTER[C-fluorescein]Y; [pH 7.4], 0.5 mM spermidine tetrachloride, and 0.2 mM spermine).
N-protected fluorescent peptide, Fmoc-T[C-fluorescein]NKTERKY; Pelleted sperm was resuspended in 1 ml HSP including 0.3%
N-protected quenched peptide, Fmoc-T[C-fluorescein]NKTER[K- n-octylglucoside and incubated for 5 min at room temperature. The
Dabcyl]Y; D-amino acid fluorescent peptide, TAE[K-fluorescein] remnants were washed twice with HSP buffer, aliquoted, and frozen
TEKAY (all D-amino acids); p417, TVNKTERAY. until use. Peptide 5PS1 was iodinated with 125I by iodogen (Pierce)-
The photoreactive peptide 5PS1 (ERYNKSE-[BPA]-L) (Spee et al., catalyzed iodination. Chromatin was dissolved in 100 l PBS and
1999) and the various fluorescent peptides were synthesized using incubated with 500 ng radio-iodinated 5PS1 in the absence or pres-
a Millipore 9050 Plus Pepsynthesiser. Fluorescein was covalently ence of ATP (1 mM) and competing peptide #417 for 2 min. This
coupled to the cysteine residue using fluorescein-5-iodoacetamide was followed by a single wash with PBS and 4 min exposure to UV
(Molecular Probes, Leiden, The Netherlands). The photoreactive light (UVP Blak-Ray B100A with Sylvania Par 38 mercury lamp) at
amino acid analog Fmoc BPA was obtained from BachemAG a distance of 2 cm (Spee et al., 1999). Samples were washed twice
(Bubendorf, Swiss). Fmoc-L-Lys(Dabcyl)-OH was obtained from with PBS before denaturation in sample buffer and analysis by SDS-
Neosystems (France). The D amino acid fluorescent peptide was PAGE. Coomassie-stained protein spots corresponding to the radio-
synthesized with an aminidated carboxyl terminus. All other pep- labeled spots were excised after separation by 2D-IEF/SDS-PAGE.
tides had a free COOH terminus. All peptides were HPLC purified Following in-gel trypsin digestion, the resulting peptides were ana-
(95% pure) and further validated by mass spectrometry. lyzed by HPLC and mass spectrometry (Q-Tof mass spectrometer,
Micromass, Manchester, UK).
MHC Class I Stability
Cos7 cells were transiently transfected with VSV-bLAP in pMT2 or Peptide Degradation Analysis
mock transfected with the empty pMT2 vector. Forty-eight hours Cells on coverslips were placed on an inverted Zeiss Axiovert 135
after transfection, cells were cultured for 30 min in methionine/ microscope equipped with a dry Achroplan 63 (NA 0.75) objective.
cysteine-free RPMI followed by labeling with 200 Ci 35S-methio- Peptides were quantified by their red appearance (Dabcyl) using
nine/cysteine for 1 hr. Cells were lysed in NP40-containing lysis photospectrometry and mixed with Fura Red (Molecular Probes) as
mixture and split into equal halves. One half was incubated at 4C a microinjection marker. Excitation of both fluorescein and Fura Red
and the other at 37C for 30 min followed by immunoprecipitation was at 475 nm. A single cell was microinjected while simultaneously
with the mAb W6/32. measuring fluorescence of a selected region containing the injected
cell. Emission of fluorescein and Fura Red was measured after split-
ting the emitted light using a 580 nm dichroic mirror, and simultane-Peptide Translocation
ously detected with PTI model 612 analog photomultipliers. For dataTen micrograms of the fluorescent peptide T[C-fluorescein]
acquisition, FELIX software (PTI Inc., USA) was used. For FRETNKTERKY was radioiodinated with 400 Ci Na125I by chloroamine T
analysis, fluorescein and TMR were excited at 475 or 545 nm. Emis-catalyzed iodination. Peptide translocation was performed at 37C
sion of fluorescein and TMR was measured after splitting the emittedwith microsomes from human LCL cells in the presence or absence
light using a 580 nm dichroic mirror with a 480–530 filter for fluores-of 10 mM ATP for the times indicated. Translocated peptides were
cein emission and a 590 filter for TMR emission, and simultaneouslyisolated by Con A-Sepharose (Neefjes et al., 1993).
detected with PTI model 612 analog photomultipliers.
Confocal Fluorescence Microscopy and FRAP Experiments
Confocal analysis of living cells was performed using a Leica TCS Acknowledgments
SP2 confocal system equipped with an Ar/Kr laser. For ATP deple-
tion, cells were incubated for 30 min with a mixture of NaAz (0.05%) We would like to thank Carla Herberts, Helen Pickersgill, and Maar-
and 2-deoxyglucose (50 M) (Reits et al., 1997). For visualizing pep- ten Fornerod for critical reading and helpful suggestions, and Wil-
tide binding to chromatin in vitro, peptides were mixed with isolated lemien Benckhuijsen and Henk Hilkman for peptide synthesis and
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sion between the cytoplasm and the nucleus, a circular spot in the
ReferencesER was bleached at full laser power, and an attenuated laser beam
was used to monitor fluorescence levels in multiple regions (using
Arrio-Dupont, M., Foucault, G., Vacher, M., Douhou, A., and Cribier,Leica TCS time lapse). For line-scan FRAP analysis an external ArKr
S. (1997). Mobility of creatine phosphokinase and beta-enolase inlaser (25 mW) was coupled into the back focal plane of the objective
cultured muscle cells. Biophys. J. 73, 2667–2673.via the epifluorescence excitation port, using a 30/70 beamsplitter,
thus allowing simultaneous imaging and spot bleaching. Spots of Basu, S., Binder, R.J., Ramalingam, T., and Srivastava, P.K. (2001).
Immunity
108
CD91 is a common receptor for heat shock proteins gp96, hsp90, Paz, P., Brouwenstijn, N., Perry, R., and Shastri, N. (1999). Discrete
proteolytic intermediates in the MHC class I antigen processinghsp70, and calreticulin. Immunity 14, 303–313.
pathway and MHC I-dependent peptide trimming in the ER. Immu-Benham, A.M., and Neefjes, J.J. (1997). Proteasome activity limits
nity 11, 241–251.the assembly of MHC class I molecules after IFN-gamma stimula-
Phair, R.D., and Misteli, T. (2000). High mobility of proteins in thetion. J. Immunol. 159, 5896–5904.
mammalian cell nucleus. Nature 404, 604–609.Beninga, J., Rock, K.L., and Goldberg, A.L. (1998). Interferon-gamma
Poo, M., and Cone, R.A. (1974). Lateral diffusion of rhodopsin in thecan stimulate post-proteasomal trimming of the N terminus of an
photoreceptor membrane. Nature 247, 438–441.antigenic peptide by inducing leucine aminopeptidase. J. Biol.
Chem. 273, 18734–18742. Reits, E.A., and Neefjes, J.J. (2001). From fixed to FRAP: measuring
protein mobility and activity in living cells. Nat. Cell Biol. 3, E145–Binder, R.J., Blachere, N.E., and Srivastava, P.K. (2001). Heat shock
E147.protein-chaperoned peptides but not free peptides introduced into
the cytosol are presented efficiently by major histocompatibility Reits, E.A.J., Benham, A.M., Plougastel, B., Neefjes, J., and Trows-
complex I molecules. J. Biol. Chem. 276, 17163–17171. dale, J. (1997). Dynamics of proteasome distribution in living cells.
EMBO J. 16, 6087–6094.Burley, S.K., David, P.R., Sweet, R.M., Taylor, A., and Lipscomb,
W.N. (1992). Structure determination and refinement of bovine lens Reits, E.A., Vos, J.C., Gromme, M., and Neefjes, J. (2000). The major
leucine aminopeptidase and its complex with bestatin. J. Mol. Biol. substrates for TAP in vivo are derived from newly synthesized pro-
224, 113–140. teins. Nature 404, 774–778.
Cascio, P., Hilton, C., Kisselev, A.F., Rock, K.L., and Goldberg, A.L. Rock, K.L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L.,
(2001). 26S proteasomes and immunoproteasomes produce mainly Hwang, D., and Goldberg, A.L. (1994). Inhibitors of the proteasome
N-extended versions of an antigenic peptide. EMBO J. 20, 2357– block the degradation of most cell proteins and the generation of
2366. peptides presented on MHC class I molecules. Cell 78, 761–771.
Cole, N.B., Smith, C.L., Sciaky, N., Terasaki, M., Edidin, M., and Roelse, J., Gromme, M., Momburg, F., Hammerling, G., and Neefjes,
Lippincott-Schwartz, J. (1996). Diffusional mobility of Golgi proteins J. (1994). Trimming of TAP-translocated peptides in the endoplasmic
in membranes of living cells. Science 273, 797–801. reticulum and in the cytosol during recycling. J. Exp. Med. 180,
1591–1597.Ellenberg, J., Siggia, E.D., Moreira, J.E., Smith, C.L., Presley, J.F.,
Worman, H.J., and Lippincott-Schwartz, J. (1997). Nuclear mem- Schubert, U., Anton, L.C., Gibbs, J., Norbury, C.C., Yewdell, J.W.,
brane dynamics and reassembly in living cells: targeting of an inner and Bennink, J.R. (2000). Rapid degradation of a large fraction of
nuclear membrane protein in interphase and mitosis. J. Cell Biol. newly synthesized proteins by proteasomes. Nature 404, 770–774.
138, 1193–1206. Schumacher, T.N., Heemels, M.T., Neefjes, J.J., Kast, W.M., Melief,
Falk, K., Rotzschke, O., Stevanovic, S., Jung, G., and Rammensee, C.J., and Ploegh, H.L. (1990). Direct binding of peptide to empty
H.G. (1991). Allele-specific motifs revealed by sequencing of self- MHC class I molecules on intact cells and in vitro. Cell 62, 563–567.
peptides eluted from MHC molecules. Nature 351, 290–296. Serwold, T., Gonzales, F., Kim, J., Jacob, R., and Shastri, N. (2002).
Fruci, D., Niedermann, G., Butler, R.H., and van Endert, P.M. (2001). ERAAP customizes peptides for MHC class I molecules in the endo-
Efficient MHC class I-independent amino-terminal trimming of epi- plasmic reticulum. Nature 419, 480–483.
tope precursor peptides in the endoplasmic reticulum. Immunity 15, Soullam, B., and Worman, H.J. (1995). Signals and structural features
467–476. involved in integral membrane protein targeting to the inner nuclear
membrane. J. Cell Biol. 130, 15–27.Geier, E., Pfeifer, G., Wilm, M., Lucchiari-Hartz, M., Baumeister, W.,
Eichmann, K., and Niedermann, G. (1999). A giant protease with Spee, P., Subjeck, J., and Neefjes, J. (1999). Identification of novel
potential to substitute for some functions of the proteasome. Sci- peptide binding proteins in the endoplasmic reticulum: ERp72, cal-
ence 283, 978–981. nexin, and grp170. Biochemistry 38, 10559–10566.
Gromme, M., van der Valk, R., Sliedregt, K., Vernie, L., Liskamp, Takeda, S., and McKay, D.B. (1996). Kinetics of peptide binding to
R., Hammerling, G., Koopmann, J.O., Momburg, F., and Neefjes, J. the bovine 70 kDa heat shock cognate protein, a molecular chaper-
(1997). The rational design of TAP inhibitors using peptide substrate one. Biochemistry 35, 4636–4644.
modifications and peptidomimetics. Eur. J. Immunol. 27, 898–904. Villanueva, M.S., Fischer, P., Feen, K., and Pamer, E.G. (1994). Effi-
Gurdon, J.B. (1976). Injected nuclei in frog oocytes: fate, enlarge- ciency of MHC class I antigen processing: a quantitative analysis.
ment, and chromatin dispersal. J. Embryol. Exp. Morphol. 36, Immunity 1, 479–489.
523–540. Wallner, B.P., Hession, C., Tizard, R., Frey, A.Z., Zuliani, A., Mura,
Koopmann, J.O., Albring, J., Huter, E., Bulbuc, N., Spee, P., Neefjes, C., Jahngen-Hodge, J., and Taylor, A. (1993). Isolation of bovine
J., Hammerling, G.J., and Momburg, F. (2000). Export of antigenic kidney leucine aminopeptidase cDNA: comparison with the lens
peptides from the endoplasmic reticulum intersects with retrograde enzyme independent of binding to HSC70. Transplantation 64, 1460–
protein translocation through the Sec61p channel. Immunity 13, 1467.
117–127. Yewdell, J.W. (2001). Not such a dismal science: the economics
Lippincott-Schwartz, J., Snapp, E., and Kenworthy, A. (2001). Study- of protein synthesis, folding, degradation and antigen processing.
ing protein dynamics in living cells. Nat. Rev. Mol. Cell Biol. 2, Trends Cell Biol. 11, 294–297.
444–456.
Mattaj, I.W., and Englmeier, L. (1998). Nucleocytoplasmic transport:
the soluble phase. Annu. Rev. Biochem. 67, 265–306.
Meyvis, T.K., De Smedt, S.C., Van Oostveldt, P., and Demeester, J.
(1999). Fluorescence recovery after photobleaching: a versatile tool
for mobility and interaction measurements in pharmaceutical re-
search. Pharm. Res. 16, 1153–1162.
Mo, X.Y., Cascio, P., Lemerise, K., Goldberg, A.L., and Rock, K.
(1999). Distinct proteolytic processes generate the C and N termini
of MHC class I-binding peptides. J. Immunol. 163, 5851–5859.
Montoya, M., and Del Val, M. (1999). Intracellular rate-limiting steps
in MHC class I antigen processing. J. Immunol. 163, 1914–1922.
Neefjes, J.J., Momburg, F., and Hammerling, G.J. (1993). Selective
and ATP-dependent translocation of peptides by the MHC-encoded
transporters. Science 261, 769–771.
